Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03829930
Title Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors George Washington University

prostate adenocarcinoma


Entinostat + Enzalutamide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.